PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 1, 2024Acta Marisiensis. Seria Medica0 citationsOpen Access

Parameters of dynamic spirometry before and after administration of salbutamol in COPD patients

View Full Paper
MRMedžida RustempašićMDMuamer Dervišević

Key Points

Key points are not available for this paper at this time.

Abstract

Abstract Introduction The aim of this research was to examine the existence of broncho-obstruction of the airways in patients suffering from chronic obstructive pulmonary disease, as well as changes in resistance values in this part of the bronchial tree after inhalation of salbutamol. Methods This study was designed as a prospective, interventional clinical trial that included a sample of 147 patients suffering from COPD. Patients were stratified into four groups of thirty patients each based on the severity of airflow limitation (based on the post-bronchodilator FEV1 value), according to the GOLD grade. The test was conducted at the University Clinical Center Sarajevo, Clinic for Lung Diseases and Tuberculosis “Podhrastovi” Results The results of our research showed that the average values of FEV1 compared to the predicted values of this parameter in subjects in the GOLD 4 group before the administration of salbutamol were statistically significantly lower than the average values of FEV1 in other subjects of the GOLD group. After the administration of salbutamol, a statistically significant increase in the value of FEV1 was registered in all tested groups. When the response to salbutamol was compared among the GOLD groups, it was assessed that the difference in the percentage increase in predicted FEV1 values after the administration of salbutamol among the tested groups was not statistically significant. Conclusion Bronchodilation with salbutamol and additional ipratropium had a significant effect on both mentioned parameters, especially in the COPD group, which speak in favor of the presence of increased peripheral resistance in all groups of patients. A statistically significant bronchodilator response was obtained in GOLD 1 and GOLD 2 groups, i.e. in groups of patients with milder forms of the disease.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Rustempašić et al. (2024) studied this question.

synapsesocial.com/papers/68e5a0a6b6db64358753b33dhttps://doi.org/10.2478/amma-2024-0019
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Evaluation of Respiratory Impedance in Asthma and COPD by an Impulse Oscillation System2010 · 101 citations
  2. 2Global Initiative for Chronic Obstructive Lung Disease2002 · 5,872 citations
  3. 3International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study2007 · 2,384 citations
  4. 4GOLD 2024: a brief overview of key changes2023 · 29 citations
  5. 5Efficacy of Salmeterol Xinafoate in the Treatment of COPD1999 · 520 citations